Status:
COMPLETED
Effects of Anti-HIV Therapy on Red Blood Cells of HIV-infected Mothers and Their Infants
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
Cord Blood
Eligibility:
All Genders
Brief Summary
This collaborative investigation between NIEHS, Duke University, and the University of North Carolina (UNC) will study red blood cells of babies born to HIV-infected women receiving anti-retroviral tr...
Detailed Description
This is an observational study of pregnant women and their newborns. The population will include 10 HIV infected women on any antiretroviral regimen and their newborn infants and 10 healthy women on n...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA: (Treated Group)
- HIV-infected
- Pregnant
- Treatment with antiretroviral regimen
- INCLUSION CRITERIA: (Control Group)
- Healthy Pregnant Female
- EXCLUSION CRITERIA: (Treated Group)
- None
- EXCLUSION CRITERIA: (Control Group)
- Delivery less than 32 weeks gestation
Exclusion
Key Trial Info
Start Date :
June 25 2004
Trial Type :
OBSERVATIONAL
End Date :
December 28 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00342082
Start Date
June 25 2004
End Date
December 28 2007
Last Update
July 2 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina Hospitals
Chapel Hill, North Carolina, United States, 27599-7030
2
Duke University Medical Center
Durham, North Carolina, United States, 27710
3
NIEHS, Research Triangle Park
Research Triangle Park, North Carolina, United States, 27709